Tatiana Zauer Curi

Tatiana Zauer Curi

Auto-generated profile, based on publicly available information

Tatiana Zauer Curi

Laboratory of Electrophysiology and Cardiovascular Pharmacology, Faculty of Health Sciences, Federal University of Grande Dourados (UFGD), Dourados, MS, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2019 in Journal of Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
GSGabriela Neubert da Silva
Gabriela Neubert da Silva
TCTatiana Zauer Curi
Tatiana Zauer Curi
STSara Emília Lima Tolouei
Sara Emília Lima Tolouei
MPMarcella Tapias Passoni
Marcella Tapias Passoni
GHGiovanna Beatriz Sari Hey
Giovanna Beatriz Sari Hey
PDPaulo Roberto Dalsenter
Paulo Roberto Dalsenter

31 July 2019 in Toxicological Sciences
Verified
Journal Article
Closed access
TCTatiana Zauer Curi
Tatiana Zauer Curi
GSGabriela Neubert da Silva
Gabriela Neubert da Silva
MPMarcella Tapias Passoni
Marcella Tapias Passoni
STSara Emilia Lima Tolouei
Sara Emilia Lima Tolouei
HMHeloísa Meldola
Heloísa Meldola
AMAnderson Martino-Andrade
Anderson Martino-Andrade
A previous study has demonstrated exposure of Brazilian pregnant women to diisopentyl phthalate (DiPeP), which reduces fetal rat testosterone production in a dose-responsive manner. In this study, we examined gene expression of steroidogenic proteins in rat fetal testes and investigated the effects of in utero and lactational DiPeP exposure on male rat reproductive development and function. For the prenatal experiment, we orally exposed pregnant Wistar rats to DiPeP or di-n-butyl phthalate (reference phthalate) at 0, 125, 250, and 500 mg/kg/day from gestation day 14–18 and the fetal testis was evaluated for transcript expression of Star, Cyp11a1, Cyp17a1, Cyp19a1, Insl3, Ar, Esr1, Esr2, and Gper1 by real-time quantitative PCR (RT-qPCR). Diisopentyl phthalate lowered mRNA levels of key steroidogenic proteins, lending support to the previously reported reductions in fetal testosterone production. Diisopentyl phthalate also lowered fetal testis transcript levels of Insl3 and changed gene expression of some steroid hormones receptors. For the postnatal experiment, pregnant rats were exposed orally to vehicle (canola oil) and 4 DiPeP doses (1, 10, 100, and 300 mg/kg/day) between gestation day 10 and postnatal day 21. Diisopentyl phthalate induced a range of reproductive and antiandrogenic effects that are typical of the rat phthalate syndrome, including reduced anogenital distance at the highest dose, reduced weight of seminal vesicles at 10 mg/kg/day and above, and testicular morphological and functional changes. Signs of fetal toxicity were observed at the highest dose. Together, our results indicate that DiPeP, a compound relevant to the human exposure scenario, is one of the most active antiandrogenic phthalates.

1 August 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
RPRhanany Alan Calloi Palozi
Rhanany Alan Calloi Palozi
BLBethânia Rosa Lorençone
Bethânia Rosa Lorençone
Lucas Pires GuarnierLucas Pires Guarnier
Lucas Pires Guarnier
PRPaulo Vitor Moreira Romão
Paulo Vitor Moreira Romão
AMAline Aparecida Macedo Marques
Aline Aparecida Macedo Marques
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior

1 October 2021 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
STSara Emilia Lima Tolouei
Sara Emilia Lima Tolouei
TCTatiana Zauer Curi
Tatiana Zauer Curi
LKLislaine Maria Klider
Lislaine Maria Klider
AJArquimedes Gasparotto Junior
Arquimedes Gasparotto Junior
Cardiovascular diseases (CVDs) are a group of non-communicable disorders of the heart and blood vessels. Although lifestyle changes as well as pharmacological treatments and surgical interventions are available in many countries, CVDs are still considered the number one cause of mortality worldwide. Hence, considering that most CVDs are caused by genetic and environmental imbalances, micro-RNAs (miRNAs or miRs) appear as a plausible therapeutic option for CVDs as they are able to regulate a wide number of genes due to multiple target sites in different genes. Since miRNA-30 and -145 have been shown to play critical roles in the cardiovascular system, acting as important regulators of many functions and biological processes, this review focuses on summarizing recent findings on their involvement in CVDs, mainly as targets for therapeutic intervention. Therefore, the biology, mechanisms of action and data on what has been discovered so far regarding miRNA-30 and 145 as therapeutic targets for CVDs are presented.